Filing Details
- Accession Number:
- 0001209191-11-046561
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-02 16:53:19
- Reporting Period:
- 2011-08-31
- Filing Date:
- 2011-09-02
- Accepted Time:
- 2011-09-02 16:53:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1009356 | Salix Pharmaceuticals Ltd | SLXP | Pharmaceutical Preparations (2834) | 943267443 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1053880 | F John Chappell | 8510 Colonnade Center Drive Raleigh NC 27615 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-08-31 | 2,000 | $31.14 | 537,604 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 16,000 | Indirect | By Spouse |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Option to Buy Common Stock | $17.63 | 2015-06-09 | 15,000 | 15,000 | Direct | |
Common Stock | Option to Buy Common Stock | $18.87 | 2014-06-17 | 22,500 | 22,500 | Direct | |
Common Stock | Option to Buy Common Stock | $7.60 | 2013-07-24 | 15,000 | 15,000 | Direct | |
Common Stock | Option to Buy Common Stock | $4.07 | 2012-07-02 | 15,000 | 15,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2015-06-09 | 15,000 | 15,000 | Direct |
2014-06-17 | 22,500 | 22,500 | Direct |
2013-07-24 | 15,000 | 15,000 | Direct |
2012-07-02 | 15,000 | 15,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.08 to $31.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- Options are 100% vested.